The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity.

International Journal of Radiation Oncology, Biology, Physics
S A KruegerB Marples

Abstract

An association between low-dose hyper-radiosensitivity (HRS) and the "early" G2/M checkpoint has been established. An improved molecular understanding of the temporal dynamics of this relationship is needed before clinical translation can be considered. This study was conducted to characterize the dose response of the early G2/M checkpoint and then determine whether low-dose radiation sensitivity could be increased by synchronization or chemical inhibition of the cell cycle. Two related cell lines with disparate HRS status were used (MR4 and 3.7 cells). A double-thymidine block technique was developed to enrich the G2-phase population. Clonogenic cell survival, radiation-induced G2-phase cell cycle arrest, and deoxyribonucleic acid double-strand break repair were measured in the presence and absence of inhibitors to G2-phase checkpoint proteins. For MR4 cells, the dose required to overcome the HRS response (approximately 0.2 Gy) corresponded with that needed for the activation of the early G2/M checkpoint. As hypothesized, enriching the number of G2-phase cells in the population resulted in an enhanced HRS response, because a greater proportion of radiation-damaged cells evaded the early G2/M checkpoint and entered mitosis with...Continue Reading

References

Jul 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·I Turesson, M C Joiner
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·M C JoinerI Turesson
Jun 14, 2001·International Journal of Radiation Biology·S C ShortM C Joiner
Sep 24, 2002·The Journal of Biological Chemistry·Baoguang ZhaoBin-Bing S Zhou
Jan 31, 2003·Nature·Christopher J Bakkenist, Michael B Kastan
Jan 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Anthony ChalmersBrian Marples
Jul 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Jackie HarneyMichele I Saunders
Jun 28, 2005·DNA Repair·Markus Löbrich, Penny A Jeggo
Feb 24, 2007·Radiation Research·S A KruegerB Marples
Oct 19, 2007·Nature Reviews. Cancer·Markus Löbrich, Penny A Jeggo
Oct 31, 2007·International Journal of Radiation Oncology, Biology, Physics·Sarah A KruegerBrian Marples
Apr 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Brian Marples, Spencer J Collis

❮ Previous
Next ❯

Citations

Oct 18, 2012·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Hongge WuJing Cheng
Oct 22, 2013·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Yan-Xia ZhaoJing Cheng
Jul 2, 2014·Cancer Letters·Lynn M MartinLaure Marignol
Jan 22, 2014·International Journal of Radiation Oncology, Biology, Physics·James D TuckerGregory W Auner
May 23, 2013·Cancer Letters·Lynn M MartinLaure Marignol
Sep 14, 2012·The British Journal of Radiology·D GuiradoA M Lallena
Apr 15, 2011·International Journal of Radiation Oncology, Biology, Physics·Sean S ParkBrian Marples
Apr 20, 2011·International Journal of Radiation Biology·Jerry R WilliamsJohn B Little
Aug 21, 2013·International Journal of Radiation Biology·Anne-Catherine HeuskinStephane Lucas
Jun 25, 2015·International Journal of Radiation Oncology, Biology, Physics·Jessica WobbBrian Marples
Jan 15, 2014·International Journal of Radiation Oncology, Biology, Physics·Dorota SłoninaAnna Gasińska
Dec 3, 2014·International Journal of Radiation Oncology, Biology, Physics·Isheeta SethJames D Tucker
May 1, 2012·Cell Cycle·Yulan ChengJohn M Abraham
Mar 24, 2015·Trends in Pharmacological Sciences·Delphine SéhédicEmmanuel Garcion
Jun 25, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Joshua T DilworthBrian Marples
Jun 4, 2016·International Journal of Radiation Biology·Claude DionetPierre Verrelle
Jul 16, 2016·The British Journal of Radiology·Richard P Hill
Dec 18, 2015·Dose-response : a Publication of International Hormesis Society·Peng ZhangC-M Ma
Feb 22, 2018·International Journal of Radiation Biology·Junfeng LiuFei Ye
Jan 16, 2018·Radiology and Oncology·Igor PiotrowskiJulian Malicki
Feb 16, 2018·Frontiers in Cardiovascular Medicine·Christopher B SylvesterK Jane Grande-Allen
Sep 5, 2013·Physics in Medicine and Biology·A-C HeuskinS Lucas
May 13, 2020·International Journal of Radiation Biology·Lukasz LaskowskiCarmel Mothersill
Mar 18, 2016·International Journal of Oncology·Yunbao PanYongchang Wei
Apr 22, 2018·Journal of Mathematical Biology·Oluwole OlobatuyiThomas Hillen
Jul 14, 2020·Neuro-oncology·Muayad F AlmahariqJoshua T Dilworth
Aug 24, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter W NagleRob P Coppes
Oct 13, 2020·International Journal of Radiation Oncology, Biology, Physics·Natalie Y L NgoiDavid S P Tan
Aug 27, 2021·The Journal of Steroid Biochemistry and Molecular Biology·Janice García-QuirozLorenza Díaz
Mar 30, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xingyan JuXiaoran Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
B Marples, Spencer J Collis
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Henriette B Honoré, Søren M Bentzen
International Journal of Radiation Oncology, Biology, Physics
Lian XueSaijun Fan
© 2021 Meta ULC. All rights reserved